Please login to the form below
Making sense of Nutraceuticals in China
Published in eyeforpharma February 2017 by Marc Yates
The Chinese nutraceutical market is considered the third largest in the world after the US and Japan, or the fourth largest if Europe is counted as a single market. Despite strong fundamentals and high rates of annual growth, though, the Chinese market remains some way from realizing its true potential. Its evolution is muddied by ambiguities around what nutraceuticals actually are and how they should be managed...
http://www.researchpartnership.com/news/2017/02/article-making-sense-of-nutraceuticals-in-china/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Healthcare in the age of AI: How will artificial intelligence impact future decision-making?
- Authored by: Constanza Salas, Jhon Galindo and Rachel Howard
Research Partnership
- Therapy Watch launches new tracker covering Postpartum Depression
- The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry
Research Partnership
- Value-based pricing reform: Strengthening the ‘front door’ to the Colombian pharmaceutical market
- Authored by: Marc Garcia and Tania Rodrigues
Research Partnership
- Infographic: Rare Diseases in China
- How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.
Research Partnership
- New syndicated COPD report now available
- Living with COPD 2023
Research Partnership
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics.
Research Partnership
